Searchable abstracts of presentations at key conferences in endocrinology

ea0044ep64 | (1) | SFEBES2016

A case of anterior hypopituitarism as the initial presentation in pituitary metastasis from breast cancer

Gunawardena Vindya , Candelario-Cosme Madeline , Lilienfeld Howard

Pituitary metastasis has been reported in about 6–8% of the breast cancer patients. Diabetes insipidus is the most common initial presentation in metastatic lesions of the pituitary. Anterior pituitary lobe lacks a direct blood supply and involvement usually is due to spread from the posterior lobe. We present a case of a 68-year-old female with known stage IV breast cancer with bone metastasis on trastuzumab, lapatinib and anastrozole who presented with hypotension, leth...

ea0090p605 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

A new referral pathway to the multidisciplinary team for inpatients with diabetic foot pathology

Brazell Madeline , Nahaboo Solim Muzammil , Rios Turek Natalia , Ashwell Simon

Background: In any given week, 2.5% of diabetic patients have a foot ulcer. In the United Kingdom (UK), there are 7000 lower limb amputations in people with diabetes every year and the annual NHS expenditure on diabetic foot-related healthcare amounts to £1 billion. As per the National Institute for Health and Care Excellence guidelines in the UK, a person with diabetes needs to be referred to an MDT within 24 h of finding a foot ulcer. The National Diabetes Footcare Audi...

ea0094s4.2 | Hacking the reproductive clock | SFEBES2023

Fertility preservation in 2023

Madeleine Dolmans Marie

The advances in cancer therapy over the past two decades have led to remarkable improvements in survival rates, but treatments such as chemotherapy, radiotherapy and/or surgery can induce premature ovarian insufficiency (POI) in some circumstances. Fertility preservation (FP) is therefore a key challenge for these women. At diagnosis, all women affected by cancer should benefit from an informed consultation on the threat of compromising their fertility with planned cancer trea...

ea0081yi11 | Young Investigator Awards | ECE2022

Diagnosing pancreatic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1 in daily practice

Pieterman Carolina , Van Beek Dirk-Jan , Wessels Frank J , van de Ven Annenienke C , de Herder Wouter W , Dekkers Olaf M , Zandee Wouter T , Drent Madeline L , Bisschop Peter H , Havekes Bas , Borel Rinkes Inne HM , Vriens Menno R , Valk Gerlof D

Background: Pancreatic Neuroendocrine Tumors (PanNETs) are highly prevalent in Multiple Endocrine Neoplasia type 1 (MEN1) and one of the main causes of mortality. Conventional imaging is the mainstay of PanNET screening/surveillance in MEN1. This study aims to assess the diagnostic accuracy of conventional pancreatic imaging studies and to determine the added value of pancreatic fine needle aspirations (FNA) for the diagnosis of MEN1-related PanNETs.Meth...

ea0073aep206 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

The effect of renin-angiotensin-aldosterone system inhibitors on binary and continuous renal outcomes in subgroups of patients with diabetes: an extensive meta-analysis

Alsalemi Noor , Elftouh Naoual , Louis Maudeline , Sadowski Cheryl , Jean-Philippe Lafrance

IntroductionDiabetic nephropathy is the leading cause of end-stage-kidney disease (ESKD). Clinical practice guidelines recommend prescribing renin–angiotensin aldosterone system inhibitors (RAASi) to prevent diabetic nephropathy at any stage. We conducted this extensive meta-analysis to compare the effects of RAASi with placebo and other antihypertensives in adults with diabetes on binary and continuous renal outcomes to provide a comprehensive revi...

ea0094p169 | Adrenal and Cardiovascular | SFEBES2023

A comparison of hydrocortisone and prednisolone for the treatment of adrenal insufficiency

Miller Madelaine , Lazarus Katharine , Choudhury Sirazum , Peters Debbie , Tan Tricia , Meeran Karim

Background: Patients with adrenal insufficiency (AI) require glucocorticoid replacement therapy. Current Endocrine Society guidelines recommend thrice-daily hydrocortisone (15-25mg) or once-daily prednisolone (3-5mg). Concerns around prednisolone use have been based on evidence using higher doses. We have been using low-dose (2-4mg) once-daily prednisolone since 2014 for glucocorticoid replacement in adult patients with AI. This study aimed to compare the effe...

ea0051p065 | Diabetes | BSPED2017

Quality of life outcomes and glycaemic control in a paediatric diabetes population since the introduction of the Best Practice Tariff

Newbury Julia , Wei Christina , Bain Murray , Jago Madeleine , Colville Gillian

Background: To assess whether the improved service provision introduced under the new Paediatric Diabetes Best Practice Tariff, which includes increased contact with the multi-disciplinary team and greater access to psychology support, has impacted positively on the quality of life (QoL) and glycaemic control of young people with diabetes.Method: In 2011, n=55 children and young people with diabetes completed the Generic Paediatric Quality of Li...

ea0085oc9.5 | Oral Communications 9 | BSPED2022

Raising awareness of the importance of preconception counselling in young people with diabetes

Green Steve , Dublon Victoria , Meso Muriel , Burchem Melanie , Beesley Avril , Ambridge Jade , Smith Madeleine

Introduction: Pregnancy under the age of 19 is considered high-risk1; and a pregnancy with diabetes at this age further increases that risk2,3. With the correct advice and counselling, these risks can be greatly reduced. Here we describe a strategy to raise awareness by addressing this as part of regular clinic visits.Method: Prior knowledge of potential complications of pregnancy was assessed as part of a clinical consultation. Evi...

ea0059ep72 | Neuroendocrinology and pituitary | SFEBES2018

Carcinoid heart disease as the presentation of ovarian neuroendocrine tumour (NET) in the absence of liver metastases

Arambewela Maulee , Al-Mukhtar Ahmed , Macdonald Madeleine , Denis Andrew , O'toole Laurence , Munir Alia

Ovarian neuroendocrine tumours are rare (< 2% gynaecological tumours) and first described in 1939 by Stewart et al. The occurrence of carcinoid heart disease alongside this is anecdotal. We present a previously fit 66 year old female, with a 6 month history of shortness of breath and ankle oedema. Echocardiogram revealed severe fixed tricuspid regurgitation, pulmonary valve disease, dilated right heart chambers and preserved left ventricular function. Carcinoid heart disea...

ea0037ep734 | Pituitary: clinical | ECE2015

Association of serum IGF1 concentration with efficacy and safety measures in adults with GH deficiency with different GH treatment regimes: a randomised clinical trial

van Bunderen Christa C. , Lips Paul , Kramer Mark H. , Drent Madeleine L.

Introduction: The current guidelines state that the goals of growth hormone (GH) therapy should be an appropriate clinical response and avoidance of side effects. The target level for IGF1 is commonly the upper half of the reference range, although no published studies offer specific guidance in this regard. Therefore, the aim of the present study is to investigate associations between IGF1 levels within the reference range and several efficacy and safety measures of GH treatm...